FDA has issued Emergency Use Authorization for Lungpacer Medical's novel Diaphragmatic Pacing Therapy System (DPTS) for immediate use in patients on invasive mechanical ventilators at high risk of weaning failure, including COVID-19 patients.
The Translational Genomics Research Institute, an affiliate of City of Hope, is looking for patients recovered from COVID-19 to participate in the COVID Immunity Study.
The Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions Inc. are collaborating to support the manufacturing of Johnson & Johnson's lead investigational COVID-19 vaccine candidate.
The National Academy of Sciences announced the election of 120 members and 26 international members in recognition of their distinguished and continuing achievements in original research.
As part of responding to the COVID-19 pandemic, hospitals across the nation had dramatically reduced their surgery schedules when UC Davis cancer patient Marlene Blake had surgery for breast cancer in March.
This pandemic has affected a lot of people, both physicians and patients, physically as well as emotionally.
March 1, 2020, started as a good day at the Montefiore Einstein Center for Cancer Care in New York.
Nobody knew how to even begin to predict the number of people who would register for the first-ever virtual annual meeting of the American Association for Cancer Research.
Early data from two randomized phase III studies of the antiviral drug remdesivir make it a viable treatment for COVID-19.
AACR data from China and Europe amount to “two different messages” for cancer patients with COVID-19
Are COVID-19 patients with cancer at a greater risk of dying than non-cancer patients? Depends on whom you ask.
